IPO Review for the week of April 7th: IPO's outperform S&P500. Again.

Loading...
Loading...
4:00 p.m. on Friday April 11th wraps up another bustling week for IPO's. Nine companies priced this week for the first time. Last Week's new issues netted IPO investors a 12.6% gain by close of trading on Friday. While not quite making a double-digit return this week, IPO investors found gains over 5.5% still out pacing the market's 2.5% decline.
This week, the market saw openings for Phibro Animal Health Corp
PAHC
, Farmland Partners
FPI
, Enable Midstream Partners
ENBL
, Zoe's Kitchen
ZOES
, Cerulean Pharma
CERU
, Adamas Pharmaceuticals
ADMS
, Ally Financial
ALLY
, iKang Healthcare Group
KANG
, and La Quinta Holdings
LQ
Loading...
Loading...
. Zoe's Kitchen was this week's IPO winner, raising $88M, and returning over 65% to the new issue investors. Read the full review of Zoe's action by clicking
here.Phibro Animal Health
fought the good fight in early trading, forcing itself to buck the heavy weight of the market. The 11.8M IPO priced at $15 per share and opened higher at $16.50. IPO investors never saw red on their screen, even as the stock dipped to an intraday low of $16.12. Despite heavy selling pressure in the S&P 500, Phibro marched higher to finish off its first day at $16.85 per share. Phibro's shares were brought to market by Merrill Lynch and Morgan Stanley. The company intends to use the proceeds of its offering to repay debt and for general corporate purposes.
Farmland Partners
had the majority of its shares sent to the syndicate for sale to new investors. The company priced its 3.8M offer at $14 per share and opened just below at $13.75. The first tick represented Farmland's high for the day at $13.76. Within minutes of its open, the stock traded below $13. The remainder of the trading day, Farmland bounced between $12.50 and $13, ending its disappointing first day at $12.98. Use of the proceeds aren't likely to excite investors either as they're slated to repay debt and potentially be used for acquisition and paying distributions. On the bright side, as they do decide what to do with the proceeds, they intend to invest them, “in a manner that is consistent with our intention to qualify as a REIT.”
Enable Midstream Partners
issued 12% of total shares to new investors for $20 per share. Shares opened higher at $21.50 per share and maintained a steady march in the positive direction, closing up just over 10% at 22.29. Use of proceeds are slated for general purposes, but include growing the business through capital expenditures. They have stated that they may also pay down some of the commercial paper debt. This week's IPO's may not have given secondary market investors the returns they hope by trading through the hype, but next week is unlikely to disappoint as IPO's stack the week.
IPO's for the week of April 14th, 2014
  • City Office REIT CIO: Expected to begin trading today, City Office is expected to open Wednesday now.
  • Moelis MC: 7.3M shares are expected to price $26-$29 through Goldman and Morgan Stanley.
  • OpusBank OPB: 5.8M shares are expected to price between $31 and $34 through J.P. Morgan, Credit Suisse, Sandler O'Neill and Keefe Bruyette.
  • Scynexis SCYX: This stock has been delayed for over a week, now looking to drop the shares offered to 4.2M, while raising the pricing range to $12 to $14.
  • Quotient QTNT: Expecting to price 5M shares between $14 and $16 through UBS and Baird and Cowen.
  • TriVascular Technologies TRIV: J.P. Morgan and Credit Suisse are expecting to price 6.5M shares between $13 and $15.
  • Leju LEJU: Credit Suisse and J.P. Morgan are expecting to price 17.7M ADS between $10 and $12.
  • Sabre SABR: Expected to price 44.7M shares between $18 and $20 through Merrill Lynch, Goldman Sachs, and Morgan Stanley.
  • Vital Therapies VTL: 4.5M shares are expected to price between $13 and $15 through Merrill Lynch and Credit Suisse.
  • Weibo WB: Weibo is pricing 20M ADS for $17 to $19 through Goldman Sachs and Credit Suisse.
  • Sportsman's Warehouse SPWH: 12.5M shares are expected to price between $11 and $13 through Credit Suisse and Goldman Sachs.
Disclosure: At the time of this writing, the author holds no positions in any aforementioned securities; however, at a future time, he may choose to hold long or short positions without notice.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsIPOs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...